What clinical and symptom features and comorbid disorders characterize outpatients with anxious major depressive disorder: A replication and extension

Canadian Journal of Psychiatry

Volumn 51, Issue 13, 2006, Pages 823-835

  Fava, Maurizio ^a,b   Rush, A John ^c   Alpert, Jonathan E ^a   Carmin, Cheryl N ^d   Balasubramani, G K ^e   Wisniewski, Stephen R ^e,f   Trivedi, Madhukar H ^c   Biggs, Melanie M ^c   Shores Wilson, Kathy ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Anxiety; Anxious depression; Depression; Features; Subtype

Indexed keywords

ANXIOLYTIC AGENT; FLUOXETINE; HYPNOTIC AGENT; VENLAFAXINE;

ADULT; AGED; AGORAPHOBIA; ANXIETY; ANXIETY DISORDER; ANXIOUS DEPRESSION; ARTICLE; CLINICAL FEATURE; COMORBIDITY; DEPRESSION; DISEASE CLASSIFICATION; FEMALE; HAMILTON SCALE; HUMAN; HYPOCHONDRIASIS; INCIDENCE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OBSESSIVE COMPULSIVE DISORDER; PANIC; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; REMISSION; SOMATOFORM DISORDER; SYMPTOMATOLOGY; TREATMENT OUTCOME; ADOLESCENT; AMBULATORY CARE; METHODOLOGY; MIDDLE AGED; PRIMARY HEALTH CARE; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; ANXIETY DISORDERS; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES;

EID: 33846995166     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674370605101304     Document Type: Article

References (36)

1. Fawcett J, Kravitz HM. Anxiety syndromes and their relationship to depressive illness. J Clin Psychiatry 1983;44:8-11.
2. Joffe RT, Bagby RM, Levitt A. Anxious and nonanxious depression. Am J Psychiatry 1993;150:1257-58.
3. VanValkenburg C, Akiskal HS, Puzantian V, Rosenthal T. Anxious depressions. Clinical, family history, and naturalistic outcome - comparisons with panic and major depressive disorders. J Affect Disorders 1984;6:67-82.
4. Clayton PJ, Grove WM, Coryell W, Keller M, Hirschfeld R, Fawcett J. Follow-up and family study of anxious depression. Am J Psychiatry 1991;148:1512-17.
5. Tollefson GD, Holman SL, Sayler ME, Potvin JH. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features. J Clin Psychiatry 1994;55:50-9.
6. Flint AJ, Rifat SL. Anxious depression in elderly patients. Response to antidepressant treatment. Am J Geriat Psychiat 1997;5:107-15.
7. Davidson JR, Meoni P, Haudiquet V, Cantillon M, Hackett D. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms. Depress Anxiety 2002;16:4-13.
8. Russell JM, Koran LM, Rush AJ, Hirschfeld RM, Harrison W, Friedman ES, and others. Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression. Depress Anxiety 2001;13:18-27.
9. Fava M, Rosenbaum JF, Hoog SL, Tepner RG, Kopp JB, Nilsson ME. Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression. J Affect Disorders 2000;59:119-26.
10. Bosworth HB, Hays JC, George LK, Steffens, DC. Psychosocial and clinical predictors of unipolar depression outcome in older adults. Int J Geriatr Psych 2002;17:238-46.
11. Ramana R, Paykel ES, Cooper Z, Hayhurst H, Saxty M, Surtees PG. Remission and relapse in major depression: a two-year prospective follow-up study. Psychol Med 1995;25:1161-70.
12. Flint AJ, Rifat SL. Two-year outcome of elderly patients with anxious depression. Psychiat Res 1997;66:23-31.
13. Sanderson, WC, Beck AT, Beck J. Syndrome comorbidity in patients with major depression or dysthymia: prevalence and temporal relationships. Am J Psychiatry 1990;147:1025-28.
14. Fava M, Rankin MA, Wright EC, Alpert JE, Nierenberg AA, Pava J, and others. Anxiety disorders in major depression. Compr Psychiatry 2000;41:97-102.
15. Melartin TK, Rytsala HJ, Leskela US, Lestela-Mielonen PS, Sokero TP, Isometsa ET. Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care. J Clin Psychiatry 2002;63:126-34.
16. Fava M, Alpert JE, Carmin CN, Wisniewski SR, Trivedi MH, Biggs MM, and others. Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D. Psychol Med 2004;34:1299-308.
17. Fava M, Rush AJ, Trivedi MH, Nierenberg AA, Thase ME, Sackeim HA, and others. Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Psychiatr Clin North Am 2003;26:457-94.
18. Rush AJ, Fava M, Wisniewski SR, Lavori PW, Trivedi MH, Sackeim HA, and others. Sequenced Treatment Alternatives to Relieve Depression (STAR*D): Rationale and Design. Control Clin Trials 2004;25:119-42.
19. Bielski RJ, Lydiard RB. Therapeutic trial participants: Where do we find them and what does it cost? Psychopharmacol Bull 1997;33:75-8.
20. Zimmerman M, Mattia JI. The reliability and validity of a screening questionnaire for 13 DSM-IV Axis I disorders (the Psychiatric Diagnostic Screening Questionnaire) in psychiatric outpatients. J Clin Psychiatry 1999;60:677-83.
21. Rush AJ, Zimmerman M, Wisniewski SR, Fava M, Hollon SD, Warden D, and others. Comorbid psychiatric disorders in depressed outpatients: a preliminary report. J Affect Disorders 2005;87(1):43-55.
22. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, and others. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003;54:573-83.
23. Trivedi MH, Rush AJ, Ibrahim HM, Carmody TJ, Biggs MM, Suppes T, and others. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med 2004;34(1):73-82.
24. Linn, BS, Linn MW, Gurel L. Cumulative Illness Rating Scale. J Am Geriatr Soc 1968;16:622-26.
25. Miller MD, Paradis CF, Houck PR, Mazumdar S, Stack JA, Rifai AH, and others. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res 1992;41:237-48.
26. Miller MD, Towers A. A manual of guidelines for scoring the cumulative rating scale for geriatrics (CIRS-G). Pittsburgh (PA): Western Psychiatric Institute and Clinic. University of Pittsburgh School of Medicine; 1991.
27. Hamilton, M. A rating scale for depression. J Neurol Neurosur Psychiatry 1960;23:56-62.
28. Hamilton, M. Development of a rating scale for primary depressive illness. The British Journal of Social and Clinical Psychology 1967;6:278-96.
29. Rush AJ, Giles DE, Schlesser MA, Fulton CL, Weissenburger JE, Burns CT. The Inventory for Depressive Symptomatology (IDS): Preliminary findings. Psychiatry Res 1986;18:65-87.
30. Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH. The Inventory of Depressive Symptomatology (IDS): Psychometric properties. Psychol Med 1996;26:477-86.
31. Cleary P, Guy W. Factor analysis of the Hamilton Depression Scale. Drug Exp Clin Res 1977;1:115-20.
32. de Winter RF, Zwinderman KH, Goekoop JG. Anxious-retarded depression: relation to family history of depression. Psychiatry Res 2004;127(1-2):111-9.
33. Fava M, Hoog SL, Judge RA, Kopp JB, Nilsson ME, Gonzales JS. Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia. J Clinical Psychopharm 2002;22:137-47.
34. Malhi GS, Parker GB, Gladstone G, Wilhelm K, Mitchell PB. Recognizing the anxious face of depression. J Nerv Ment Dis 2002;190:366-73.
35. Robins E, Guze SB. Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am J Psychiatry 1970;126:983-87.
36. Fava M, Entsuah R, Tummala R. Venlafaxine Versus SSRIs and Placebo in the Treatment of Anxious Depression. Paper presented at the APA Annual Meeting; 2005; Atlanta (GA).